The rodent ventral tegmental area (VTA) and substantia nigra pars compacta (SNC) contain dopamine neurons intermixed with glutamate neurons (expressing vesicular glutamate transporter 2; VGluT2), which play roles in reward and aversion. However, identifying the neuronal compositions of the VTA and SNC in higher mammals has remained challenging. Here, we revealed VGluT2 neurons within the VTA and SNC of nonhuman primates and humans by simultaneous detection of VGluT2 mRNA and tyrosine hydroxylase (TH; for identification of dopamine neurons). We found that several VTA subdivisions share similar cellular compositions in nonhuman primates and humans; their rostral linear nuclei have a high prevalence of VGluT2 neurons lacking TH; their paranigral and parabrachial pigmented nuclei have mostly TH neurons, and their parabrachial pigmented nuclei have dual VGluT2-TH neurons. Within nonhuman primates and humans SNC, the vast majority of neurons are TH neurons but VGluT2 neurons were detected in the pars lateralis subdivision. The demonstration that midbrain dopamine neurons are intermixed with glutamate or glutamate-dopamine neurons from rodents to humans offers new opportunities for translational studies towards analyzing the roles that each of these neurons play in human behavior and in midbrain-associated illnesses such as addiction, depression, schizophrenia, and Parkinson’s disease.
The presence of dopamine neurons in the nonhuman primate and human ventral tegmental area (VTA) and substantia nigra pars compacta (SNC) has been documented for nearly half a century1,2. Nonhuman primate studies have shown that VTA and SNC dopamine neurons play fundamental roles in decision making, motivation, reward, aversion, and learning3,4. Clinical findings have led to the hypothesis that VTA and SNC midbrain dopamine neurons are involved in a variety of disorders, including addiction5, schizophrenia6, depression and other mood disorders7, and movement disorders8.
As in nonhuman primates and humans, dopamine neurons are highly concentrated in the mouse and the rat VTA and SNC, and also play fundamental roles in decision making, motivation, reward, aversion, and learning9,10. The multiple functions of the midbrain dopamine neurons are likely to be mediated by diverse phenotypes of dopamine neurons and by their associated neuronal networks, some of which have local origins. Regarding the rodent VTA cellular composition, in addition to dopamine neurons (identified by expression of tyrosine hydroxylase; TH), the rodent VTA has GABA neurons (identified by expression of glutamic acid decarboxylase or vesicular GABA transporter), and glutamate neurons (identified by expression of vesicular glutamate transporter 2; VGluT2)11. In addition to these three major phenotypes of VTA neurons, the rodent VTA has subsets of neurons that exhibit combinatorial neurotransmitter-releasing characteristics. Some of these combinatorial neurons are glutamate-dopamine neurons and others are glutamate-GABA neurons12,13,14,15,16.
In addition to anatomical studies showing that the rodent VTA has a diverse cellular composition, the participation of diverse VTA neurons in motivated behavior has been addressed by application of optogenetic approaches in transgenic rodents. Findings from these optogenetic studies have revealed discrete midbrain neuronal phenotypes that appear to play distinct roles in reward, aversion, motivation, or learning17,18,19,20,21,22,23,24,25,26,27. In contrast to the advances made in identifying unique neuronal phenotypes and their functions in the mouse and rat midbrain, the cellular composition of the dopaminergic midbrain in higher mammals, such as the nonhuman primate and human, is unknown. The lack of information on the cellular composition of the human midbrain contributes to a translational gap in our understanding of the neurobiology of addiction, depression, and other midbrain-associated disorders. To start addressing this gap, here we combined in situ hybridization and immunohistochemistry to determine the possible presence of glutamate or glutamate-dopamine neurons within the VTA and SNC in nonhuman primates and humans.
To determine whether glutamate neurons are present within the VTA or SNC of nonhuman primates and humans, we combined immunodetection of TH (to establish the boundaries and subdivisions of the VTA and SNC), with radioactive in situ hybridization to identify the neuronal expression of transcripts encoding VGluT2 mRNA (as antibodies against VGluT2 do not label cell bodies of VTA-VGluT2 neurons)11.
Detection and distribution of VGluT2-only neurons, TH-only neurons and dual VGluT2-TH neurons within the subdivisions of the marmoset VTA and SNC
In a pilot study, we found neurons expressing VGluT2-mRNA intermingled with TH-neurons in the VTA and SNC of both marmoset (Callithrix jacchus) and squirrel (Saimiri sciureus) monkeys. However, due to limited access to primate brain tissue, the quantitative cellular analysis of VGluT2-expressing neurons and TH-expressing neurons was confined to the marmoset midbrain. For each subdivision of the VTA or the SNC, we counted all identified neurons expressing VGluT2-mRNA (VGluT2-neurons), TH immunoreactivity (TH-neurons) or a combination of both (VGluT2-TH neurons).
Within the rostral VTA subdivision of the VTA (VTAR), we found mostly VGluT2-neurons that did not co-express TH (VGluT2-only neurons) (Fig. 1A,B,D). These VGluT2-only neurons constituted over 80% of all labeled VTAR neurons (Table 1). In contrast to the prevalence of VGluT2-only neurons, approximately 10% of the labeled VTAR neurons expressed TH but lacked VGluT2 (TH-only neurons). The prevalence of TH-only neurons slightly increased along the anteroposterior axis (Fig. 2A). The abundance of VGluT2-neurons within the VTAR differed from the neighboring SNC, which was dominated by TH-only neurons (Fig. 1C,E).
Within the rostral linear nucleus (RLi; most medial aspect of the VTA), approximately half of the neurons were VGluT2-only neurons or TH-only neurons (Table 1) (Figs 1D and 3A,B). The prevalence of VGluT2-only neurons within the RLi decreased as the prevalence of TH-only neurons increased along the anteroposterior axis (interaural 5.5 to 4.5) (Fig. 2B), such that in the most anterior aspect of the RLi (interaural 5.5), 65.10% ± 13.50% of the counted RLi neurons were VGluT2-only neurons and 30.72% ± 14.09% were TH-only neurons. In contrast to the anterior RLi, approximately one-third of the neurons in the posterior aspect of the RLi (interaural 4.5) were VGluT2-only neurons (33.59% ± 2.76%) and two-thirds were TH-only neurons (66.41% ± 2.76%). The decreasing prevalence of RLi VGluT2-only neurons and increasing prevalence of TH-only neurons continued into the contiguous caudal linear nucleus (CLi; interaural 4.0), which contained near to one-quarter of VGluT2-only neurons and three-quarters of TH-only neurons (Table 1) (Figs 2B and 4A,B). Despite the decreased prevalence of VGluT2-only neurons from the anterior to the posterior aspects of the VTA, a small population of VGluT2-only neurons was observed in the caudal VTA subdivision (VTAC; Table 1) and the rest were TH-only neurons (Figs 1D and 4C). Dual VGluT2-TH neurons were rarely observed in the VTAC.
Within the interfascicular nucleus (IF), a medioventral subdivision of the VTA, approximately one-quarter of the labeled neurons were VGluT2-only neurons and about three-quarters were TH-only neurons (Table 1) (Figs 1D and 3C). Similar to the RLi, the frequency of VGluT2-only neurons decreased along the anteroposterior axis of the IF, while the frequency of TH-only neurons increased (Fig. 2C). We found that within the paranigral nucleus (PN) of the VTA, the VGluT2-only neurons constituted near to one-third of the total labeled neurons and the rest were TH-only neurons (Table 1), and this prevalence was maintained along the anteroposterior axis (Figs 1D,2D and 3D). Within the parainterfascicular nucleus (PIF) of the VTA, about one-fifth of neurons were VGluT2-only neurons and near to three-quarters were TH-only neurons (Table 1) (Fig. 1D).
We determined that within the PBP of the VTA about one-quarter of the labeled neurons were VGluT2-only neurons, and more than half were TH-only neurons (Table 1) (Fig. 1D). Among all marmoset VTA subdivisions, the PBP had the highest frequency of dual VGluT2-TH neurons, representing 18.03 ± 3.47% of all counted PBP neurons (Figs 3E,4D and 5). In contrast, the prevalence of VGluT2-TH neurons was less than 7% in each of the other subdivisions of the VTA (Fig. 1D). Within the total population of VGluT2 expressing neurons 41.99% were dual VGluT2-TH neurons, and within the total population of TH-neurons 23.45% were dual VGluT2-TH neurons (Table 1). We detected the greatest numbers of dual VGluT2-TH neurons in the central portion of the PBP (at interaural level 5.0) where the proportions of VGluT2-only, TH-only and dual VGluT2-TH neurons were similar (Fig. 2E).
The marmoset SNC was dominated by TH-only neurons (Figs 1E and 5), which were prominent within the dorsal subdivision (SNCd), ventral division (SNCv), and pars medialis subdivision of the SNC (SNCm) (Table 2). We detected VGluT2-only neurons intermingled with TH-only neurons in the pars lateralis subdivision of the SNC (SNCl) (Table 2). Within the SNCl, the VGluT2 neurons represented approximately one-fifth of the labeled neurons (Figs 1E and 4E). The proportions of both VGluT2-only and TH-only neurons within the SNCl were maintained over the anteroposterior axis (Fig. 2F). We rarely found dual VGluT2-TH neurons within the SNC (Fig. 1E), and did not detect VGluT2-expressing neurons within the SNCv (Fig. 4F).
Detection and distribution of VGluT2-neurons, TH-neurons and dual VGluT2-TH neurons within the subdivisions of the human VTA and SNC
Detection of neurons in the human VTA has remained challenging due to limited access to brain tissue and in most instances, receipt of brain tissue that has endured substantial loss of mRNA, the integrity of which is necessary for the cellular identification of neurons expressing VGluT2 mRNA. To optimize the cellular detection of both TH-protein and VGluT2-mRNA, human brains were maintained in ice and were immediately fixed by perfusion instead of by fixed immersion into a fixative solution. The optimal molecular and cellular preservation of the human brain tissue allowed us to combine immunodetection of TH (to establish the boundaries and subdivisions of the VTA and SNC) and radioactive in situ hybridization to identify neuronal expression of transcripts encoding VGluT2 mRNA.
As in rodents and in nonhuman primates, we detected neurons expressing VGluT2 mRNA intermingled with TH-neurons in the human VTA and SNC. We found that the human VTA and SNC shared a distribution of VGluT2 neurons similar to that observed in the marmoset. Within the human VTA, we detected the highest prevalence of VGluT2-only neurons in the RLi (42.04% ± 7.44% of RLi neurons; Table 3). In contrast to the infrequency of dual VGluT2-TH neurons in the marmoset RLi (less than 3% of neurons), we found that dual VGluT2-TH neurons in the human RLi represented one-tenth of the labeled RLi neurons. As in the marmoset, the TH-only neurons in the human RLi constituted approximately half of the RLi neurons (Fig. 6A–D).
In common with the marmoset PBP, the human PBP contained VGluT2-only, TH-only and dual VGluT2-TH neurons. We found that in the human PBP about 60% of the labeled neurons were TH-only neurons and 20% were VGluT2-only neurons (Table 3). In common with the marmoset findings, we detected within the human PBP the highest prevalence of dual VGluT2-TH neurons (Fig. 6B,E). We further estimated that within the human PBP the dual VGluT2-TH neurons represented 39.45% of the total population of VGluT2-expressing neurons and 18.19% of the total population of TH-expressing neurons (Table 3).
The VGluT2-only, TH-only and dual VGluT2-TH neurons were also detected in the VTA region located between the PBP and RLi, known as the ‘VTA subdivision’ of the VTA (VTASUB)28 (Fig. 6F). We found that within the total population of VTASUB neurons over three-quarters of these neurons were TH-only neurons, 10% were VGluT2-only neurons and 10% were VGluT2-TH neurons (Table 3). However, within the total population of VGluT2-expressing neurons, 41.77% were dual VGluT2-TH neurons and within the total population of TH-neurons 11.32% were dual VGluT2-TH neurons. In contrast to the high frequency of dual VGluT2-TH neurons detected in the PBP and the VTASUB, the PN neurons were largely segregated into VGluT2-only neurons and TH-only neurons, and dual VGluT2-TH neurons were rarely observed (Table 3) (Fig. 6G).
As in the marmoset SNC, the human SNCd, SNCv, and SNCm subdivisions of the SNC were dominated by TH-only neurons (Table 4). In addition, we detected VGluT2 neurons in the human SNCl that in their vast majority did not co-express TH (Table 4) (Figs 7 and 8). While we did not detect VGluT2-neurons in the marmoset SNCv, a small population of VGluT2-neurons was identified in the human SNCv.
The conservation of VTA and SNC dopamine neurons from mouse to human has long been established29,30,31. However, recent findings from mouse and rat studies have shown that in addition to dopamine neurons, the rodent VTA and SNC have glutamate neurons13,14,32,33. These rodent glutamate neurons are diverse in their biochemical composition, neuronal signaling, and target areas15,34. Furthermore, rodent VTA glutamate neurons play roles in aversion24,35,36 or reward25. Here, we provide evidence for the presence of glutamate neurons within the VTA and SNC in nonhuman primates and humans. These neurons may play similar roles as those ascribed to their rodent counterpart. As such, the human VTA glutamate neurons may contribute to reward and aversion, and VTA-related illnesses, such as depression or addiction. In this regard, a human VTA microarray gene expression screening has shown that expression of VGluT2 mRNA is higher in VTA samples from individuals with a history of nicotine abuse, compared with control subjects37.
Studies in nonhuman primates have shown that putative dopamine neurons in the VTA and SNC, identified by their electrophysiological properties, are activated in response to unpredicted rewards, shift their activation to predictors of reward following cue-reward learning, and omission of an expected reward depresses putative dopamine neuron activity38,39,40,41,42,43,44,45,46,47,48,49. These different firing patterns reflective of reward prediction have been a cornerstone of theories regarding how these dopamine neurons participate in everyday decision making, as well as a variety of human disorders involving dopamine signaling, such as addiction, depression, movement disorders, impulse control disorders, and schizophrenia4,5,7,8,50,51,52,53,54,55,56,57,58,59. Importantly, studies in mice and rats have confirmed the dopamine nature of reward prediction signaling by midbrain dopamine neurons26,60,61,62,63. Additional studies from electrophysiological recordings in nonhuman primates have shown that subsets of midbrain putative dopamine neurons are responsive to punishers and their predictors64. Taken together, the nonhuman primate electrophysiological findings have provided evidence for functional heterogeneity among putative dopamine neurons, which may reflect diversity in their biochemical composition or their neuronal connectivity. However, information on nonhuman primate midbrain neuronal phenotypes and their neuronal connectivity are very limited. In contrast, substantial progress has been made recently in elucidating a great diversity among the midbrain dopamine neurons and among their intermixed nondopamine neurons, and the involvement of these different types of neurons in a variety of motivated behaviors15,19,22,24,27,35,65,66,67,68.
Recent rat and mouse studies have shown that VTA glutamate neurons establish local and long-range connections that participate in different types of synapses and behaviors. At the local and synaptic levels, the VTA glutamate neurons establish multiple asymmetric synapses on single neighboring dopamine neurons; these synapses mediate glutamate-receptor-dependent firing of some of the dopamine neurons that innervate the nucleus accumbens25,69. At the VTA local level, activation of glutamate neurons mediates reward that depends on activation of local glutamatergic receptors25. While most of the mouse and rat VTA-glutamate neurons lack both dopaminergic and GABAergic markers, within the midline aspects of the VTA there are subpopulations of glutamate neurons that co-express molecules for the synthesis and vesicular accumulation of either dopamine14,32,70 or GABA15. Emerging evidence suggests that each subpopulation of glutamate-dopamine neurons, glutamate-GABA neurons, and glutamate-only neurons target selective neuronal populations within different brain structures. For instance, the fibers from VTA glutamate-dopamine neurons establish asymmetric excitatory synapses on dendritic spines of medium spiny neurons (MSNs) within the nucleus accumbens34, and the optical activation of these glutamate-dopamine fibers excites both MSNs12,71 and cholinergic interneurons72. A recent study has demonstrated that in the nucleus accumbens individual axons from glutamate-dopamine neurons has the capability to release dopamine and glutamate from mutually exclusive microdomains34. As such, a single glutamate-dopamine axon may provide to accumbal MSNs or cholinergic interneurons both fast excitatory signaling (via glutamate) and prolonged modulatory signaling (via dopamine). In addition to the nucleus accumbens, the dual VTA glutamate-dopamine neurons innervate the medial prefrontal cortex14,73, where they target parvalbumin-expressing interneurons, and contribute to perseverative behaviors73. In contrast to the participation of dual glutamate-dopamine neurons in a mesocortical pathway, the glutamate-GABA neurons provide the major input from the VTA to the lateral habenula15. Individual axon terminals from these mesohabenular glutamate-GABA neurons establish a balance of excitatory and inhibitory control on glutamate neurons within the lateral habenula15. Lateral habenula activation of fibers from VTA glutamate-GABA neurons induces aversion, which is mediated by activation of local glutamatergic receptors15. Regarding VTA glutamate-only neurons, a population of nucleus accumbens parvalbumin-interneurons constitutes a major target of fibers from the VTA glutamate-only neurons. These fibers establish multiple asymmetric synapses on single parvalbumin interneurons at the level of both dendrites and cell bodies36. The activation of these fibers synapsing on parvalbumin-interneurons results in the release of GABA onto accumbal MSNs, and the promotion of aversion36.
The recent findings detailed above indicate that the rodent midbrain glutamate neurons participate in different aspects of reward or aversion. In addition, some of these glutamate neurons have the capability to use both glutamate and dopamine, or glutamate and GABA as signaling molecules, and they target brain structures implicated in several brain disorders. Here, we report that as in mice and rats, the midbrain dopamine neurons of both nonhuman primates and humans are intermixed with glutamate-only and dual glutamate-dopamine neurons. However, whereas the mouse RLi is dominated by glutamate-only neurons (>80% of neurons) and the rat RLi contains approximately 60% glutamate-only neurons14,33, a lower prevalence of glutamate-only neurons is present in the marmoset RLi (~50% of RLi neurons) and human RLi (40% of RLi neurons). However, it is possible that the prevalence of human RLi glutamate neurons is increased in more anterior sections than those analyzed in the present study, as glutamate neurons dominate the most anterior portions of the mouse, rat, and marmoset RLi14,33. The decreased prevalence of glutamate-only neurons within the RLi from mouse to human is concomitant with an increase of the prevalence of dopamine-only neurons within the RLi from the mouse to human. We had previously shown that a large proportion of the rat RLi TH-expressing neurons lack the dopamine transporter (for reuptake of dopamine) and the vesicular monoamine transporter 2 (VMAT2; for accumulation of dopamine into synaptic vesicles)70,74. In contrast, nearly all rat dopamine neurons residing in the lateral VTA neighboring to the SNC (lateral PBP) co-express both the dopamine transporter and VMAT270. A similar lateral-to-medial decreasing gradient of dopamine transporter and VMAT2 expression has been observed from the PBP to the RLi in the human VTA75, suggesting that several subtypes of dopamine neurons are also present across species.
Regarding the detection and distribution of glutamate-only and dopamine-only neurons, we found that within the most anterior aspects of the marmoset VTA, where VTAR is present, the glutamate-only neurons are the major neuronal population of neurons in both the VTAR and RLi. As in mice and rats, the VTA of nonhuman primates have a decreasing gradient of glutamate-only neurons and an increasing gradient of dopamine-only neurons across the anteroposterior axis within the VTAR, RLi, and IF. However, the marmoset VTAC is an exception to these cross-species gradients, as it contains a large proportion of glutamate-only neurons (~40%), though the total number of neurons is comparatively low. Compared to mice and rats, several nuclei of the marmoset VTA (IF, PN, and PIF, CLi) show a lower proportion of glutamate-only and glutamate-dopamine neurons, and a higher prevalence of dopamine-only neurons. There are also some anatomical differences between species that are likely to contribute to differences in the prevalence of midbrain neuronal phenotypes. For instance, both VTAC of marmosets and VTASUB of humans are not present in rodents.
Regarding the detection and distribution of dual glutamate-dopamine neurons, we found that in the marmoset and human VTA these neurons are most prevalent within the lateral parts of the VTA, specifically the PBP. This prevalence and distribution are in contrast to that present in the mouse and rat VTA, in which the dual glutamate-dopamine neurons have their highest prevalence in the medial aspects of the VTA33. While we also detected dual glutamate-dopamine neurons in the human RLi and VTASUB, these neurons are infrequent in the marmoset RLi, and undetectable in the human or marmoset PN. Thus, the presence of dual glutamate-dopamine neurons is a characteristic shared by the rat RLi and human RLi, but not by the marmoset RLi. The glutamate neurons of the rat PBP and PN are exclusively located within their most medial portions, which contain a high prevalence of dual glutamate-dopamine neurons13,14. In contrast to the prevalence of dual glutamate-dopamine neurons in the medial aspects of the PBP and PN in the rat13,14, the marmoset and human PBP contain glutamate-dopamine neurons in both of their medial and lateral aspects. In this context, in primates the firing patterns of putative midbrain dopamine neurons related to reward prediction, reward, aversion, or value have largely been identified in the lateral parts of the midbrain, which include the lateral PBP43,44,47,48,76,77,78. Thus some of these recorded neurons within the lateral PBP may correspond to dual glutamate-dopamine neurons, as the primate lateral PBP contains the largest population of dual glutamate-dopamine neurons, suggesting glutamate-dopamine neurons might participate in reward-prediction signaling.
From our findings, we suggest that the observed activation of medial and lateral portions of the human dopaminergic midbrain measured by imaging studies is likely to include the participation of glutamate-only and glutamate-dopamine neurons intermingled with the dopamine-only neurons. Imaging studies have shown functional MRI signal changes in the medial, lateral, or both parts of the human VTA in response to a variety of motivation-related stimuli, including the consumption of drugs of abuse79,80,81,82,83,84,85,86,87. Portions of the human medial VTA, which appear to include the RLi and PN, exhibit increased reactivity during threat processing88,89, and pain anticipation90. Although the cellular phenotypes of the medial VTA that mediate the observed increased reactivity cannot be determined by imaging, based on our findings of human cellular characterization within the RLi and PN (Fig. 8), it is possible that, in addition to human VTA dopamine neurons, the VTA glutamate neurons located in the medial aspects of the human VTA participate in the documented increased reactivity within the VTA during threat processing or pain anticipation. As in the human medial VTA, glutamate neurons are also present in the mouse and rat medial VTA. Regarding medial VTA glutamate neurons, we had previously identified within the mouse RLi and PN a subset of glutamate neurons that innervate the lateral habenula, and are involved in aversive conditioning24. Regarding medial VTA dopamine neurons, in vivo recordings in the rat have shown that dopamine neurons of the rat PN exhibit elevated firing rates in response to noxious stimuli91. Thus, we suggest that both glutamate and dopamine neurons of the human medial VTA are likely to play roles in aversive processing.
Human imaging studies have shown that the ventromedial SNC exhibits activity reflective of reward prediction while the dorsolateral SNC exhibits activity reflective of aversion prediction92. The neuronal activity of the dorsolateral SNC has also been shown to exhibit increased firing rates in response to both rewarding and aversive stimuli while ventromedial SNC neurons exhibit increased firing rates only to rewarding stimuli64. These human and nonhuman primate functional findings suggest functional heterogeneity within the SNC that may reflect, in part, neuronal heterogeneity within the SNC. In this regard, we present evidence that glutamate neurons are confined to the SNCl, which is the most dorsolateral SNC subdivision in humans and marmosets, and a similar distribution is observed in the rat32. Given that the VTA glutamate neurons are involved in aversive conditioning24, it is conceivable that the SNCl glutamate neurons have a similar behavioral function. However, further research will be necessary to determine the distinct influences of each SNCl neuronal phenotype in motivated behavior.
In summary, we provide evidence that 1) glutamate-only, dopamine-only, and dual glutamate-dopamine neurons are present within the marmoset and human VTA, the prevalence of which depends upon the VTA subdivision; and 2) a population of glutamate-only neurons is present within the SNCl subdivision, while the SNC is otherwise dominated by dopamine-only neurons. The discovery that glutamate-only, dopamine-only, and dual glutamate-dopamine neurons are differentially distributed within the midbrain dopamine systems from rodents to humans will allow further exploration of the specific roles that these different neurons play in behavior. Specifically, the advances made in identifying distinct neuronal phenotypes, together with the analysis of their functions by application of optogenetic methodologies in transgenic rodents, where cell-specific manipulations can be made, provides a foundation for investigating human-related midbrain-associated illnesses. Findings from the present studies may provide useful information on determining the unique contributions of individual VTA neuronal phenotypes in disorders such as addiction. Within this context, recent advancements in magnetic strength used in imaging studies may allow the evaluation of the functions of discrete VTA subdivisions in humans93.
Nonhuman primate tissue collection
All animal procedures were performed in accordance with National Institutes of Health Guidelines, and approved by the National Institute of Neurological Disorders and Stroke Animal Care and Use Committee. Three male marmosets were deeply anesthetized with ketamine hydrochloride (10 mg/kg, iv) followed by sodium pentobarbital (15 mg/kg, iv). Marmosets were perfused transcardially with 0.9% NaCl containing 2% sodium nitrite (800 ml) to flush blood from the vascular system, followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.0, 1 L). Brains were extracted, stored in 4% paraformaldehyde overnight at room temperature, and on the next day changed to a 16% sucrose/1% paraformaldehyde solution in PB at 4 °C. Brains were frozen in isopentane and stored at −80 °C until sectioning. The VTA was coronally sectioned (12 μm) in a cryostat and stored in 24 tubes containing 30% sucrose/30% polyethylene glycol in RNAse-free PB.
Human tissue collection
Two subjects were processed for autopsy in Saint Borbála Hospital, Tatabánya, Department of Pathology. Informed consent was obtained for the use of brain tissue and for access to medical records for research purposes. Tissue was obtained and used in a manner compliant with the Declaration of Helsinki. All procedures were approved by the Regional and Institutional Committee of Science and Research Ethics of Scientific Council of Health (ETT TUKEB 31443/2011/EKU (518/PI/11)). Brains were extracted between 2.5 to 3.5 hours post mortem. Both internal carotid and vertebral arteries were cannulated, and the brains were perfused first with physiological saline (1.5 liters for 30 minutes) containing 5 ml of heparin, followed by a fixative solution containing 4% paraformaldehyde, 0.05% glutaraldehyde and 0.2% picric acid in 0.1 M PB (pH 7.4, 4–5 liters for 1.5–2 hours). After perfusion the brains were postfixed in the same fixative solution overnight, but without glutaraldehyde94. Brains were then stored in 0.1 M PB with sodium azide while shipping to NIDA facilities. Next, brains were stored in 18% sucrose at 4 °C, frozen in isopentane, and stored at −80 °C until sectioning. The VTA was coronally sectioned (12 μm) in a cryostat and stored in 180 tubes containing 30% sucrose/30% polyethylene glycol in water. Subject 1 was a 55 year old male and cause of death was pulmonary embolism with acute cor pulmonale. Subject 2 was a 70 year old female and cause of death was subsequent ST segment elevation myocardial infarction of the inferior wall. Subjects had no history of neurological disease.
In situ hybridization and immunohistochemistry
Sections were incubated for 10 min in PB containing 0.5% Triton X-100, rinsed two times for 5 min each with PB, treated with 0.2 N HCl for 10 min, rinsed two times for 5 min each with PB, and then acetylated in 0.25% acetic anhydride in 0.1 M triethanolamine, pH 8.0, for 10 min. Sections were rinsed two times for 5 min each with PB and postfixed with 4% PFA for 10 min. Before hybridization and after a final rinse with PB, the free-floating sections were incubated in hybridization buffer (50% formamide, 10% dextran sulfate, 5X Denhardt’s solution, 0.62 M NaCl, 50 mM DTT, 10 mM EDTA, 20 mM PIPES, pH 6.8, 0.2% SDS, 250 μg/ml salmon sperm DNA, 250 μg/ml tRNA) for 2 h at 55 °C. Sections were hybridized for 16 h at 55 °C in hybridization buffer containing [35S]- and [33P]-labeled single-stranded antisense of marmoset VGluT2 (nucleotides 674–2422; GenBank accession number XM_002755104.3) or human VGluT2 (nucleotides 707–4394; GenBank accession number NM_020346.1), probes at 107 cpm/ml. Sections were treated with 4 μg/ml RNase A at 37 °C for 1 h, washed with 1X SSC, 50% formamide at 55 °C for 1 h, and with 0.1X SSC at 68 °C for 1 h. After the last SSC wash, sections were rinsed with PB and incubated for 1 h in PB supplemented with 4% bovine serum albumin and 0.3% Triton X-100. This was followed by the overnight incubation at 4 °C with an anti-TH mouse monoclonal antibody (1:500; MAB 318; Millipore) for which specificity has been documented95. After being rinsed three times for 10 min each in PB, sections were processed with an ABC kit (Vector Laboratories). The material was incubated for 1 h at room temperature in a 1:200 dilution of the biotinylated secondary antibody, rinsed with PB, and incubated with avidin-biotinylated horseradish peroxidase for 1 h. Sections were rinsed and the peroxidase reaction was then developed with 0.05% 3, 3-diaminobenzidine-4 HCl and 0.03% hydrogen peroxide. Free-floating sections were mounted on coated slides. Slides were dipped in Ilford K.5 nuclear tract emulsion (Polysciences; 1:1 dilution in double distilled water) and exposed in the dark at 4 °C for 4 weeks before development.
Data analysis of cellular subpopulations
Sections were photographed with bright-field, darkfield, and epiluminescence microscopy using an Olympus VS-100 microscope. Single- and double-labeled neurons were observed within each traced region at high power (20X objective lens) and marked electronically. Subdivisions of the marmoset VTA were traced according to a marmoset brain atlas96. At anteroposterior levels where the rostral VTA subdivision was present, neurons within the 3N were considered to belong to the rostral VTA. At anteroposterior levels where the VTAR subdivision was not present, neurons within the 3N were considered to belong to the PBP subdivision. The few scattered neurons identified in the ventral tegmental decussation (vtgx) were considered to belong to the RLi.
Subdivisions of the human VTA were traced based on the human brainstem atlas97 and descriptions of TH-expressing neuronal morphologies that define midbrain subdivisions28. The PBP was delineated based on the presence of TH-expressing neurons that were oriented parallel to the lateral circumference of the red nucleus. The lateral border of the PBP was the substantia nigra and dorsal border was ventral to the A8 field. We refer to the nucleus termed “VTA”28 as the VTASUB. The VTASUB was delineated based on the presence of mediolaterally-oriented TH-expressing neurons. The PN was delineated based on small TH-expressing neurons proximal the midline. The RLi nucleus was delineated based on TH-expressing neurons that were oriented parallel to the medial circumference of the red nucleus.
TH/VGluT2 double-labeled material was analyzed using epiluminescence to increase the contrast of silver grains (neither dark-field nor bright-field optics allow clear visualization of silver grains when colocalized with high concentration of immunoproducts). A cell was considered to express VGluT2 mRNA when its soma contained concentric aggregates of silver particles above background level. A neuron was considered to express TH immunoreactivity when its soma was clearly labeled as brown. A TH-immunolabeled neuron was included in the calculation of total population of TH cells when the stained cell was at least 5 μm in diameter. The cells expressing VGluT2 mRNA, TH immunoreactivity, or both markers were counted separately. To determine cellular coexistence of VGluT2 mRNA and TH immunolabel, silver grains corresponding to VGluT2 expression were focused under epiluminescence microscopy, the path of epiluminescence light was blocked without changing the focus, and bright-field light was used to determine whether a brown neuron, expressing TH in focus, contained the aggregates of silver grains seen under epiluminescence. Labeled cells were counted three times, each time by a different observer. Pictures were adjusted to match contrast and brightness by using Adobe Photoshop (Adobe Systems).
For human data analysis, six sections from each brain were analyzed and neurons were counted only on the right hemisphere. Counters were blinded from subject-identifying information (e.g., gender, cause of death, age). Mean neuronal phenotype per subdivision was computed by averaging the percent of neurons (i.e., 10 VGluT2-only RLi neurons/20 total RLi neurons) from each section. For marmoset data analysis, twenty four sections were analyzed (11 from Dew, 8 from Turk, and 5 from Wen) and neurons were counted only on the right hemisphere, except for the midline structures (RLi and IF) which were counted in their entirety. For subdivisional analyses across the anteroposterior axis, mean neuronal phenotype per subdivision was computed by averaging the percent of neurons from one section per marmoset at each anteroposterior position (interaural 6.0 mm to 4.5 mm with a 0.5 mm interval). For subdivisional analyses without regard for anteroposterior position, mean neuronal phenotype per subdivision was computed as detailed above in the human sample analysis but for all sections in which the subdivision was identified.
Accession codes: marmoset VGluT2 (GenBank accession number XM_002755104.3) & human VGluT2 (GenBank accession number NM_020346.1).
How to cite this article: Root, D. H. et al. Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans. Sci. Rep. 6, 30615; doi: 10.1038/srep30615 (2016).
Olson, L., Boreus, L. O. & Seiger, A. Histochemical demonstration and mapping of 5-hydroxytryptamine- and catecholamine-containing neuron systems in the human fetal brain. Z Anat Entwicklungsgesch 139, 259–282 (1973).
Garver, D. L. & Sladek, J. R. Jr. Monoamine distribution in primate brain. I Catecholamine-containing perikarya in the brain stem of Macaca speciosa. J Comp Neurol 159, 289–304 (1975).
Schultz, W. Behavior-related activity of primate dopamine neurons. Rev Neurol (Paris) 150, 634–639 (1994).
Bromberg-Martin, E. S., Matsumoto, M. & Hikosaka, O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815–834 (2010).
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R. & Telang, F. Imaging dopamine’s role in drug abuse and addiction. Neuropharmacology 56 Suppl 1, 3–8 (2009).
Howes, O. D. & Kapur, S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull 35, 549–562 (2009).
Nestler, E. J. & Carlezon, W. A. Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59, 1151–1159 (2006).
Lotharius, J. & Brundin, P. Pathogenesis of Parkinson’s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3, 932–942 (2002).
Wise, R. A. & Rompre, P. P. Brain dopamine and reward. Annu Rev Psychol 40, 191–225 (1989).
Deutch, A. Y. & Roth, R. H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85, 367–402, discussion 402-363 (1990).
Morales, M. & Root, D. H. Glutamate neurons within the midbrain dopamine regions. Neuroscience 282C, 60–68 (2014).
Stuber, G. D., Hnasko, T. S., Britt, J. P., Edwards, R. H. & Bonci, A. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. The Journal of neuroscience: the official journal of the Society for Neuroscience 30, 8229–8233 (2010).
Yamaguchi, T., Sheen, W. & Morales, M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 25, 106–118 (2007).
Yamaguchi, T., Wang, H. L., Li, X., Ng, T. H. & Morales, M. Mesocorticolimbic glutamatergic pathway. J Neurosci 31, 8476–8490 (2011).
Root, D. H. et al. Single rodent mesohabenular axons release glutamate and GABA. Nat Neurosci 17, 1543–1551 (2014).
Trudeau, L. E. et al. The multilingual nature of dopamine neurons. Prog Brain Res 211, 141–164 (2014).
Stamatakis, A. M. et al. A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 80, 1039–1053 (2013).
Adamantidis, A. R. et al. Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior. J Neurosci 31, 10829–10835 (2011).
Lammel, S. et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 491, 212–217 (2012).
van Zessen, R., Phillips, J. L., Budygin, E. A. & Stuber, G. D. Activation of VTA GABA neurons disrupts reward consumption. Neuron. 73, 1184–1194, 2012 Mar 1121 (2012).
Bocklisch, C. et al. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science 341, 1521–1525 (2013).
Tan, K. R. et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 73, 1173–1183 (2012).
Steinberg, E. E. & Janak, P. H. Establishing causality for dopamine in neural function and behavior with optogenetics. Brain Res 1511, 46–64 (2013).
Root, D. H., Mejias-Aponte, C. A., Qi, J. & Morales, M. Role of glutamatergic projections from ventral tegmental area to lateral habenula in aversive conditioning. J Neurosci 34, 13906–13910 (2014).
Wang, H. L., Qi, J., Zhang, S., Wang, H. & Morales, M. Rewarding Effects of Optical Stimulation of Ventral Tegmental Area Glutamatergic Neurons. J Neurosci 35, 15948–15954 (2015).
Chang, C. Y. et al. Brief optogenetic inhibition of dopamine neurons mimics endogenous negative reward prediction errors. Nat Neurosci 19, 111–116 (2016).
Lerner, T. N. et al. Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits. Cell 162, 635–647 (2015).
McRitchie, D. A., Hardman, C. D. & Halliday, G. M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364, 121–150 (1996).
Oades, R. D. & Halliday, G. M. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434, 117–165 (1987).
German, D. C., Schlusselberg, D. S. & Woodward, D. J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J Neural Transm 57, 243–254 (1983).
Haber, S. N. & Knutson, B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 35, 4–26 (2010).
Yamaguchi, T., Wang, H. L. & Morales, M. Glutamate neurons in the substantia nigra compacta and retrorubral field. The European journal of neuroscience 38, 3602–3610 (2013).
Yamaguchi, T., Qi, J., Wang, H. L., Zhang, S. & Morales, M. Glutamatergic and dopaminergic neurons in the mouse ventral tegmental area. Eur J Neurosci 41, 760–772 (2015).
Zhang, S. et al. Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Nat Neurosci 18, 386–392 (2015).
Lammel, S. et al. Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron 85, 429–438 (2015).
Qi, J. et al. Glutamatergic efferents from the ventral tegmental area to nucleus accumbens drive aversion by acting on GABAergic interneurons. Nature Neuroscience 19, 725–733 (2016).
Flatscher-Bader, T., Zuvela, N., Landis, N. & Wilce, P. A. Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area. Hum Mol Genet 17, 38–51 (2008).
Hollerman, J. R. & Schultz, W. Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci 1, 304–309 (1998).
Bayer, H. M. & Glimcher, P. W. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron 47, 129–141 (2005).
Fabre, M., Rolls, E. T., Ashton, J. P. & Williams, G. Activity of neurons in the ventral tegmental region of the behaving monkey. Behav Brain Res 9, 213–235 (1983).
Kawagoe, R., Takikawa, Y. & Hikosaka, O. Reward-predicting activity of dopamine and caudate neurons–a possible mechanism of motivational control of saccadic eye movement. J Neurophysiol 91, 1013–1024 (2004).
Nakahara, H., Itoh, H., Kawagoe, R., Takikawa, Y. & Hikosaka, O. Dopamine neurons can represent context-dependent prediction error. Neuron 41, 269–280 (2004).
Matsumoto, M. & Hikosaka, O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447, 1111–1115 (2007).
Mirenowicz, J. & Schultz, W. Importance of unpredictability for reward responses in primate dopamine neurons. J Neurophysiol 72, 1024–1027 (1994).
Morris, G., Arkadir, D., Nevet, A., Vaadia, E. & Bergman, H. Coincident but distinct messages of midbrain dopamine and striatal tonically active neurons. Neuron 43, 133–143 (2004).
Satoh, T., Nakai, S., Sato, T. & Kimura, M. Correlated coding of motivation and outcome of decision by dopamine neurons. J Neurosci 23, 9913–9923 (2003).
Schultz, W., Apicella, P. & Ljungberg, T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13, 900–913 (1993).
Tobler, P. N., Fiorillo, C. D. & Schultz, W. Adaptive coding of reward value by dopamine neurons. Science 307, 1642–1645 (2005).
Waelti, P., Dickinson, A. & Schultz, W. Dopamine responses comply with basic assumptions of formal learning theory. Nature 412, 43–48 (2001).
Hyman, S. E., Malenka, R. C. & Nestler, E. J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29, 565–598 (2006).
Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J. & Frith, C. D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442, 1042–1045 (2006).
Glimcher, P. W. Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci USA 108 Suppl 3, 15647–15654 (2011).
Hyman, S. E. Addiction: a disease of learning and memory. Am J Psychiatry 162, 1414–1422 (2005).
Schultz, W. Getting formal with dopamine and reward. Neuron 36, 241–263 (2002).
Juckel, G. et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 29, 409–416 (2006).
Schultz, W. Potential vulnerabilities of neuronal reward, risk, and decision mechanisms to addictive drugs. Neuron 69, 603–617 (2011).
D’Ardenne, K., McClure, S. M., Nystrom, L. E. & Cohen, J. D. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 319, 1264–1267 (2008).
Wise, R. A. Roles for nigrostriatal–not just mesocorticolimbic–dopamine in reward and addiction. Trends Neurosci 32, 517–524 (2009).
Davis, K. L., Kahn, R. S., Ko, G. & Davidson, M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148, 1474–1486 (1991).
Cohen, J. Y., Haesler, S., Vong, L., Lowell, B. B. & Uchida, N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 482, 85–88 (2012).
Mileykovskiy, B. & Morales, M. Duration of inhibition of ventral tegmental area dopamine neurons encodes a level of conditioned fear. J Neurosci 31, 7471–7476 (2011).
Eshel, N. et al. Arithmetic and local circuitry underlying dopamine prediction errors. Nature 525, 243–246 (2015).
Eshel, N., Tian, J., Bukwich, M. & Uchida, N. Dopamine neurons share common response function for reward prediction error. Nat Neurosci 19, 479–486 (2016).
Matsumoto, M. & Hikosaka, O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459, 837–841 (2009).
Mejias-Aponte, C. A., Ye, C., Bonci, A., Kiyatkin, E. A. & Morales, M. A subpopulation of neurochemically-identified ventral tegmental area dopamine neurons is excited by intravenous cocaine. J Neurosci 35, 1965–1978 (2015).
Grieder, T. E. et al. VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nat Neurosci 17, 1751–1758 (2014).
Margolis, E. B., Hjelmstad, G. O., Fujita, W. & Fields, H. L. Direct bidirectional mu-opioid control of midbrain dopamine neurons. J Neurosci 34, 14707–14716 (2014).
Eddine, R. et al. A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine. Sci Rep 5, 8184, doi: 8110.1038/srep08184 (2015).
Dobi, A., Margolis, E. B., Wang, H. L., Harvey, B. K. & Morales, M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30, 218–229 (2010).
Li, X., Qi, J., Yamaguchi, T., Wang, H. L. & Morales, M. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain structure & function 218, 1159–1176 (2013).
Tecuapetla, F. et al. Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 30, 7105–7110 (2010).
Chuhma, N., Mingote, S., Moore, H. & Rayport, S. Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling. Neuron 81, 901–912 (2014).
Kabanova, A. et al. Function and developmental origin of a mesocortical inhibitory circuit. Nat Neurosci 18, 872–882 (2015).
Root, D. H. et al. Norepinephrine activates dopamine D4 receptors in the rat lateral habenula. J Neurosci 35, 3460–3469 (2015).
Gonzalez-Hernandez, T., Barroso-Chinea, P., De La Cruz Muros, I., Del Mar Perez-Delgado, M. & Rodriguez, M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 479, 198–215 (2004).
Fiorillo, C. D., Tobler, P. N. & Schultz, W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299, 1898–1902 (2003).
Tobler, P. N., Dickinson, A. & Schultz, W. Coding of predicted reward omission by dopamine neurons in a conditioned inhibition paradigm. J Neurosci 23, 10402–10410 (2003).
Mirenowicz, J. & Schultz, W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 379, 449–451 (1996).
Breiter, H. C., Aharon, I., Kahneman, D., Dale, A. & Shizgal, P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 30, 619–639 (2001).
Breiter, H. C. et al. Acute effects of cocaine on human brain activity and emotion. Neuron 19, 591–611 (1997).
Aron, A. et al. Reward, motivation, and emotion systems associated with early-stage intense romantic love. J Neurophysiol 94, 327–337 (2005).
Elliott, R., Friston, K. J. & Dolan, R. J. Dissociable neural responses in human reward systems. J Neurosci 20, 6159–6165 (2000).
O’Doherty, J. P., Deichmann, R., Critchley, H. D. & Dolan, R. J. Neural responses during anticipation of a primary taste reward. Neuron 33, 815–826 (2002).
Goldstein, R. Z. et al. Dopaminergic response to drug words in cocaine addiction. J Neurosci 29, 6001–6006 (2009).
Sell, L. A. et al. Activation of reward circuitry in human opiate addicts. Eur J Neurosci 11, 1042–1048 (1999).
Knutson, B. & Cooper, J. C. Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 18, 411–417 (2005).
Jasinska, A. J., Stein, E. A., Kaiser, J., Naumer, M. J. & Yalachkov, Y. Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 38, 1–16 (2014).
Cha, J. et al. Hyper-reactive human ventral tegmental area and aberrant mesocorticolimbic connectivity in overgeneralization of fear in generalized anxiety disorder. J Neurosci 34, 5855–5860 (2014).
Hennigan, K., D’Ardenne, K. & McClure, S. M. Distinct midbrain and habenula pathways are involved in processing aversive events in humans. J Neurosci 35, 198–208 (2015).
Bauch, E. M., Rausch, V. H. & Bunzeck, N. Pain anticipation recruits the mesolimbic system and differentially modulates subsequent recognition memory. Hum Brain Mapp 35, 4594–4606 (2014).
Brischoux, F., Chakraborty, S., Brierley, D. I. & Ungless, M. A. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci USA 106, 4894–4899 (2009).
Pauli, W. M. et al. Distinct Contributions of Ventromedial and Dorsolateral Subregions of the Human Substantia Nigra to Appetitive and Aversive Learning. J Neurosci 35, 14220–14233 (2015).
Eapen, M., Zald, D. H., Gatenby, J. C., Ding, Z. & Gore, J. C. Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol 32, 688–694 (2011).
Toth, K. et al. Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus. Brain 133, 2763–2777 (2010).
Tagliaferro, P. & Morales, M. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J Comp Neurol 506(4), 616–626 (2008).
Paxinos, G. The marmoset brain in stereotaxic coordinates. 1st edn, (Academic Press, 2012).
Paxinos, G. & Huang, X. F. Atlas of the human brainstem. (Academic Press, 1995).
We thank Laszlo Havas, Lynn Cournoyer, and Eduardo Gigante for technical assistance. This work was made possible due to the financial support from the Intramural Research Program (IRP) of the National Institute on Drug Abuse (IRP/NIDA/NIH) to MM, the IRP of the National Institute of Neurological Disorders and Stroke (IRP/NINDS/NIH) to ACS, and the European Research Council (grant number ERC-2011-ADG-294313, SERRACO) to ZM. Funding sources were not involved in study design, data collection and interpretation, or the decision to submit this research for publication.
The authors declare no competing financial interests.
About this article
Cite this article
Root, D., Wang, HL., Liu, B. et al. Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans. Sci Rep 6, 30615 (2016). https://doi.org/10.1038/srep30615
npj Parkinson's Disease (2022)
Molecular Psychiatry (2022)
Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors
Nature Reviews Neuroscience (2017)